These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19338644)

  • 41. A Novel Penile Splint as Early Traction Therapy After Grafting Techniques for Peyronie's Disease.
    Fernández-Pascual E; Manfredi C; Cocci A; Quintana Franco LM; Egui Rojo MA; Carballido Rodríguez J; Martínez-Salamanca JI
    J Sex Med; 2020 Sep; 17(9):1819-1824. PubMed ID: 32622768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical management of Peyronie's disease.
    Hellstrom WJ
    J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
    Levine LA; Larsen SM
    J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peyronie's disease: Contemporary evaluation and management.
    Ziegelmann MJ; Bajic P; Levine LA
    Int J Urol; 2020 Jun; 27(6):504-516. PubMed ID: 32253786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic advances in the treatment of Peyronie's disease.
    Yafi FA; Pinsky MR; Sangkum P; Hellstrom WJ
    Andrology; 2015 Jul; 3(4):650-60. PubMed ID: 26097120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The management of Peyronie's disease: evidence-based 2010 guidelines.
    Ralph D; Gonzalez-Cadavid N; Mirone V; Perovic S; Sohn M; Usta M; Levine L
    J Sex Med; 2010 Jul; 7(7):2359-74. PubMed ID: 20497306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The medical management of Peyronie's disease.
    Akin-Olugbade Y; Mulhall JP
    Nat Clin Pract Urol; 2007 Feb; 4(2):95-103. PubMed ID: 17287870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NON-SURGICAL TREATMENT OF PEYRONIE'S DISEASE: A COMPREHENSIVE REVIEW.
    Chernylovskyi VA; Krakhotkin DV; Chaikovskyi VP
    Wiad Lek; 2021; 74(3 cz 1):539-545. PubMed ID: 33813465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review of Management Options for Patients With Atypical Peyronie's Disease.
    Yafi FA; Hatzichristodoulou G; DeLay KJ; Hellstrom WJ
    Sex Med Rev; 2017 Apr; 5(2):211-221. PubMed ID: 27544298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Non-surgical management of Peyronie's disease: State of current knowledge].
    Abdessater M; Kanbar A; Gas J; Bart S; Coloby P; Beley S; Sleiman W
    Prog Urol; 2020 May; 30(6):353-364. PubMed ID: 32279954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Iontophoresis in the conservative treatment of Peyronie's disease: preliminary experience].
    Treffiletti S; Annoscia S; Montefiore F; Boccafoschi C
    Arch Ital Urol Androl; 1997 Dec; 69(5):323-7. PubMed ID: 9477619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.
    Paulis G; D'Ascenzo R; Nupieri P; De Giorgio G; Orsolini G; Brancato T; Alvaro R
    Int J Androl; 2012 Aug; 35(4):521-7. PubMed ID: 21950543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
    Paulis G; Brancato T
    Inflamm Allergy Drug Targets; 2012 Feb; 11(1):48-57. PubMed ID: 22309083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conservative treatment of Peyronie's disease: a guide.
    Cosentino M; Di Nauta M; Boeri L; Ferraioli G; Lucignani G; Ricapito A; Gadda F; Iafrate M; Mancini M; Dal Moro F; Ruiz-Castañe E; Bettocchi C; Montanari E; Sofikitis N
    World J Urol; 2024 May; 42(1):317. PubMed ID: 38740620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease.
    Heidari M; Nejadi JR; Ghate A; Delfan B; Iran-Pour E
    J Pak Med Assoc; 2010 Apr; 60(4):291-3. PubMed ID: 20419973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
    Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
    J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
    Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
    J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.